These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

54 related articles for article (PubMed ID: 24241172)

  • 1. Characterization of anti-Tn-antigen MLS128 binding proteins involved in inhibiting the growth of human colorectal cancer cells.
    Zamri N; Masuda N; Oura F; Kabayama K; Yajima Y; Nakada H; Yamamoto K; Fujita-Yamaguchi Y
    Biosci Trends; 2013 Oct; 7(5):221-9. PubMed ID: 24241172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of two monoclonal antibodies, MLS128 against Tn-antigen and 1H7 against insulin-like growth factor-I receptor, on the growth of colon cancer cells.
    Zamri N; Masuda N; Oura F; Yajima Y; Nakada H; Fujita-Yamaguchi Y
    Biosci Trends; 2012 Dec; 6(6):303-12. PubMed ID: 23337790
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Susceptibility to proteases of anti-Tn-antigen MLS128 binding glycoproteins expressed in human colon cancer cells.
    Oura F; Yajima Y; Nakata M; Taniue K; Akiyama T; Nakada H; Yamamoto K; Fujita-Yamaguchi Y
    Biosci Trends; 2015 Feb; 9(1):49-55. PubMed ID: 25787909
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of cancer cell growth by anti-Tn monoclonal antibody MLS128.
    Morita N; Yajima Y; Asanuma H; Nakada H; Fujita-Yamaguchi Y
    Biosci Trends; 2009 Feb; 3(1):32-7. PubMed ID: 20103942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MLS128 antibody-induced suppression of colon cancer cell growth is mediated by a desmocollin and a 110 kDa glycoprotein.
    Shuck SC; Hong T; Kalkum M; Igarashi R; Kajiya K; Termini J; Yamamoto K; Fujita-Yamaguchi Y
    Biosci Trends; 2019 Jul; 13(3):216-224. PubMed ID: 31168022
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surface plasmon resonance and NMR analyses of anti Tn-antigen MLS128 monoclonal antibody binding to two or three consecutive Tn-antigen clusters.
    Matsumoto-Takasaki A; Hanashima S; Aoki A; Yuasa N; Ogawa H; Sato R; Kawakami H; Mizuno M; Nakada H; Yamaguchi Y; Fujita-Yamaguchi Y
    J Biochem; 2012 Mar; 151(3):273-82. PubMed ID: 22161472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of cytokine-induced apoptosis by insulin-like growth factor-I is independent of cell adhesion molecules in HT29-D4 colon carcinoma cells-evidence for a NF-kappaB-dependent survival mechanism.
    Garrouste F; Remacle-Bonnet M; Fauriat C; Marvaldi J; Luis J; Pommier G
    Cell Death Differ; 2002 Jul; 9(7):768-79. PubMed ID: 12058282
    [TBL] [Abstract][Full Text] [Related]  

  • 8. RAV12 accelerates the desensitization of Akt/PKB pathway of insulin-like growth factor I receptor signaling in COLO205.
    Li JC; Li R
    Cancer Res; 2007 Sep; 67(18):8856-64. PubMed ID: 17875727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and expression of anti-Tn-antigen-specific single-chain antibody genes from hybridoma producing MLS128 monoclonal antibody.
    Yuasa N; Ogawa H; Koizumi T; Tsukamoto K; Matsumoto-Takasaki A; Asanuma H; Nakada H; Fujita-Yamaguchi Y
    J Biochem; 2012 Apr; 151(4):371-81. PubMed ID: 22318767
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant human insulin-like growth factor binding protein 3 inhibits growth of human epidermal growth factor receptor-2-overexpressing breast tumors and potentiates herceptin activity in vivo.
    Jerome L; Alami N; Belanger S; Page V; Yu Q; Paterson J; Shiry L; Pegram M; Leyland-Jones B
    Cancer Res; 2006 Jul; 66(14):7245-52. PubMed ID: 16849573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NO donor and MEK inhibitor synergistically inhibit proliferation and invasion of cancer cells.
    Furuhashi S; Sugita H; Takamori H; Horino K; Nakahara O; Okabe H; Miyake K; Tanaka H; Beppu T; Baba H
    Int J Oncol; 2012 Mar; 40(3):807-15. PubMed ID: 22025280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Co-targeting the EGFR and IGF-IR with anti-EGFR monoclonal antibody ICR62 and the IGF-IR tyrosine kinase inhibitor NVP-AEW541 in colorectal cancer cells.
    Cunningham MP; Thomas H; Marks C; Green M; Fan Z; Modjtahedi H
    Int J Oncol; 2008 Nov; 33(5):1107-13. PubMed ID: 18949375
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Growth inhibition of insulin-like growth factor I receptor monoclonal antibody to human colorectal cancer cells.
    Zhang Y; Zhang Y
    Cancer Invest; 2008; 26(3):230-6. PubMed ID: 18317963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Potential autocrine role of insulin-like growth factor II during suramin-induced differentiation of HT29-D4 human colonic adenocarcinoma cell line.
    Pommier GJ; Garrouste FL; el Atiq F; Roccabianca M; Marvaldi JL; Remacle-Bonnet MM
    Cancer Res; 1992 Jun; 52(11):3182-8. PubMed ID: 1375536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Purification of a colon cancer cell growth inhibitor and its identification as an insulin-like growth factor binding protein.
    Culouscou JM; Shoyab M
    Cancer Res; 1991 Jun; 51(11):2813-9. PubMed ID: 1709585
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tyrosine kinase-independent activation of extracellular-regulated kinase (ERK) 1/2 by the insulin-like growth factor-1 receptor.
    Perrault R; Wright B; Storie B; Hatherell A; Zahradka P
    Cell Signal; 2011 Apr; 23(4):739-46. PubMed ID: 21215800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neurotensin-induced Erk1/2 phosphorylation and growth of human colonic cancer cells are independent from growth factors receptors activation.
    Massa F; Tormo A; Béraud-Dufour S; Coppola T; Mazella J
    Biochem Biophys Res Commun; 2011 Oct; 414(1):118-22. PubMed ID: 21945442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of vitamin D receptor expression via estrogen-induced activation of the ERK 1/2 signaling pathway in colon and breast cancer cells.
    Gilad LA; Bresler T; Gnainsky J; Smirnoff P; Schwartz B
    J Endocrinol; 2005 Jun; 185(3):577-92. PubMed ID: 15930183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting of insulin-like growth factor-I receptor with a monoclonal antibody inhibits growth of hepatic metastases from human colon carcinoma in mice.
    Bauer TW; Fan F; Liu W; Camp ER; Yang A; Somcio RJ; Bucana CD; Singh R; Ellis LM
    Ann Surg Oncol; 2007 Oct; 14(10):2838-46. PubMed ID: 17653802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.